Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don B Sanders

Showing results (61-70 of 73) with videos related to

Pageof 8
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbationsLaura S Gold, Ryan N Hansen, Donald L Patrick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 2, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary ExacerbationsNatalie E West, Valeria V Beckett, Raksha Jain, et al.
Annals of the American Thoracic Society|November 6, 2015
ATS Core Curriculum 2015: Part III. Pediatric Pulmonary MedicineDebra Boyer, Mary Nevin, Carey C Thomson, et al.
Thorax|January 21, 2019
Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosisBenjamin T Kopp, Rohan Thompson, Jeeho Kim, et al.
Microbial Pathogenesis|April 27, 2025
An observational study of the lung microbiome and lung function in young children with cystic fibrosis across two countries with differing antibiotic practicesWangfei Wang, Yang Chen, Mladen Rasic, et al.
Annals of the American Thoracic Society|November 14, 2023
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary ExacerbationsChristina S Thornton, Lindsay J Caverly, Linda M Kalikin, et al.
Pediatric Pulmonology|March 5, 2025
Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic FibrosisHillary S Hayden, Maria T Nelson, Sydney E Ross, et al.
Annals of the American Thoracic Society|September 8, 2023
A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment StrategiesDon B Sanders, Traci M Bartz, Edith T Zemanick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbationsDon B Sanders, George M Solomon, Valeria V Beckett, et al.
American Journal of Respiratory and Critical Care Medicine|October 8, 2020
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic FibrosisLucy Perrem, Sanja Stanojevic, Michelle Shaw, et al.
Pageof 8

Showing results (61-70 of 73) with videos related to

Sort By:
Pageof 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|March 18, 2022
Health care costs in a randomized trial of antimicrobial duration among cystic fibrosis patients with pulmonary exacerbationsLaura S Gold, Ryan N Hansen, Donald L Patrick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 2, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary ExacerbationsNatalie E West, Valeria V Beckett, Raksha Jain, et al.
Annals of the American Thoracic Society|November 6, 2015
ATS Core Curriculum 2015: Part III. Pediatric Pulmonary MedicineDebra Boyer, Mary Nevin, Carey C Thomson, et al.
Thorax|January 21, 2019
Secondhand smoke alters arachidonic acid metabolism and inflammation in infants and children with cystic fibrosisBenjamin T Kopp, Rohan Thompson, Jeeho Kim, et al.
Microbial Pathogenesis|April 27, 2025
An observational study of the lung microbiome and lung function in young children with cystic fibrosis across two countries with differing antibiotic practicesWangfei Wang, Yang Chen, Mladen Rasic, et al.
Annals of the American Thoracic Society|November 14, 2023
Prevalence and Clinical Impact of Respiratory Viral Infections from the STOP2 Study of Cystic Fibrosis Pulmonary ExacerbationsChristina S Thornton, Lindsay J Caverly, Linda M Kalikin, et al.
Pediatric Pulmonology|March 5, 2025
Effects of Therapeutic Antibiotic Exposure on the Oropharyngeal and Fecal Microbiota in Infants With Cystic FibrosisHillary S Hayden, Maria T Nelson, Sydney E Ross, et al.
Annals of the American Thoracic Society|September 8, 2023
A Pilot Randomized Clinical Trial of Pediatric Cystic Fibrosis Pulmonary Exacerbations Treatment StrategiesDon B Sanders, Traci M Bartz, Edith T Zemanick, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 3, 2017
Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbationsDon B Sanders, George M Solomon, Valeria V Beckett, et al.
American Journal of Respiratory and Critical Care Medicine|October 8, 2020
Lung Clearance Index to Track Acute Respiratory Events in School-Age Children with Cystic FibrosisLucy Perrem, Sanja Stanojevic, Michelle Shaw, et al.
Pageof 8